Orbital radiotherapy for Graves' ophthalmopathy: Useful or useless? Safe or dangerous?

Journal of Endocrinological Investigation

Volumn 26, Issue 1, 2003, Pages 5-16

  Bartalena, Luigi ^a   Marcocci, C ^b   Gorman, C A ^c   Wiersinga, W M ^d   Pinchera, A ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cataract; Glucocorticoids; Graves' ophthalmopathy; Orbital radiotherapy; Radiation retinopathy; Side effects

Indexed keywords

GLUCOCORTICOID; PLACEBO; PREDNISOLONE; PREDNISONE;

ADJUVANT THERAPY; CLINICAL TRIAL; CONJUNCTIVITIS; DECOMPRESSION SURGERY; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG RESPONSE; EYE DISEASE; EYE IRRITATION; EYE SURGERY; EYELID EDEMA; GRAVES DISEASE; HAIR LOSS; HUMAN; PATIENT SELECTION; QUALITY OF LIFE; RADIATION CARCINOGENESIS; RADIATION CATARACT; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RETINOPATHY; REVIEW; SAFETY; SIDE EFFECT; SKIN IRRITATION; THYROID GLAND; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

EID: 0037214835     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345116     Document Type: Review

References (54)

1. Bartalena L., Pinchera A., Marcocci C. Management of Graves' ophthalmopathy: Reality and perspectives. Endocr. Rev. 2000, 21: 168-199.
2. Bartalena L., Tanda M.L., Medea A., Marcocci C., Pinchera A. Novel approaches to the management of Graves' ophthalmopathy. Hormones 2002, 1: 76-90.
3. Bartalena L., Marcocci C., Pinchera A. Management of thyroid eye disease. Eur. J. Nucl. Med. 2002, 29 (Suppl. 2): S458-S465.
4. Krassas G.E., Heufelder A.E. Immunosuppressive therapy in patients with thyroid eye disease: An overview of current concepts. Eur. J. Endocrinol. 2001, 144: 311-318.
5. Marcocci C., Bartalena L, Tanda M.L. et al. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study. J. Clin. Endocrinol. Metab. 2001, 86: 3562-3567.
6. Bartalena L., Marcocci C., Tanda M.L. et al. Orbital radiotherapy for Graves' ophthalmopathy. Thyroid 2002, 12: 245-250.
7. Kahaly G., Rosler H.-P., Pitz S., Hommel G. Low-versus high-dose radiotherapy for Graves' ophthalmopathy: A randomized, single blind study. J. Clin. Endocrinol. Metab. 2000, 85: 102-108.
8. Bartalena L., Marcocci C., Chiovato L. et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: Comparison with systemic corticosteroids alone. J. Clin. Endocrinol. Metab. 1983, 54: 1139-1144.
9. Marcocci C., Bartalena L., Panicucci M. et al. Orbital radiotherapy combined with high-dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: Results of a prospective study. J. Endocrinol. Invest. 1991, 14: 853-860.
10. Bartalena L. Smoking and Graves' disease. J. Endocrinol. Invest. 2002, 25: 402.
11. Gorman C.A., Garrity J.A., Fatourechi V. et al. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 2001, 108: 1523-1534.
12. Marquez S.D., Lum B.L., McDougall I.R. et al. Long-term results of irradiation for patients with progressive Graves' ophthalmopathy. Int. J. Radiat. Oncol. Biol. Phys. 2001, 51: 766-774.
13. Donaldson S.S., Bagshaw M.A., Kriss J.P. Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 1973, 37: 276-285.
14. Marcocci C., Bartalena L., Bogazzi F. et al. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: Results of a prospective study. J. Endocrinol. Invest. 1991, 14: 853-860.
15. Prummel M.F., Mourits M.P., Blank L., Koorneef L., Wiersinga M.A. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 1993, 342: 949-954.
16. Mourits M.P., Van Kempen-Harteveld M.L., Garcia Garcia M.B. et al. Radiotherapy for Graves' orbitopathy: Randomised placebo-controlled study. Lancet 2000, 355: 1505-1509.
17. Bartalena L., Marcocci C., Chiovato L. et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: Comparison with systemic corticosteroids alone. J. Clin. Endocrinol. Metab. 1983, 56: 1139-44.
18. Marcocci C., Bartalena L., Tanda M.L. et al. Comparison of the effectiveness and tolerability of intravenous and oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study. J. Clin. Endocrinol. Metab. 2001, 86: 3562-3567.
19. Juler F.A. III. Diseases of the orbit. Acute purulent keratitis in exophthalmic goitre treated by repeated tarsorrhaphy, resection of cervical sympathetic and x-rays; Retention of vision in one eye. Trans. Ophthalmol. Soc. UK 1913, 33: 58-62.
20. Borak J. Die Behandlung von Hyperthyreosen durch Rontgenbestrahlung der Hypophyse. Strahlentherapie 1935, 53: 73-89.
21. Mandeville F.B. Roentgen therapy of orbital-pituitary portals for progressive exophthalmos following subtotal thyroidectomy. Radiology 1943, 41: 268-271.
22. Jones A. Orbital x-ray therapy of progressive exophthalmos. Br. J. Radiol. 1951, 24: 637-646.
23. Smitt M.C., Donaldson, S.S. Radiation therapy for benign disease of the orbit. Semin. Radiat. Oncol. 1999; 9: 179-189.
24. Prummel M.F., Mourits M.P., Blank L. et al. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 1993, 342: 949-954.
25. Perros P., Kendall-Taylor P. Natural history of thyroid eye disease. Thyroid 1998, 8: 423-425.
26. Gorman C.A. The measurement of change in Graves' ophthalmopathy. Thyroid 1998, 8: 539-543.
27. Gorman C.A. Clever is not enough: NOSPECS is form in search of function. Thyroid 1991, 1: 353-355.
28. Mourits M.P., Koornneef L., Wiersinga W.M. et al. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: A novel approach. Br. J. Ophthalmol. 1989, 73: 639-644.
29. Burch H.B., Wartofsky L. Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr. Rev. 1993, 14: 747-793.
30. Mourits M.P., Van Kempen-Harteveld M.L., Garcia M.B.G. et al. Radiotherapy for Graves' orbitopathy: Randomized placebo-controlled study. Lancet 2001, 355: 1505-1509.
31. Gorman C.A., Garrity J.A., Fatourechi V. et al. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 2001, 108: 1523-1534.
32. Gorman C.A., Garrity J.A., Fatourechi V. et al. The aftermath of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 2002, in press.
33. Van Ruyven R.I., Van Den Bosch W.A., Mulder P.G. et al. The effect of retrobulbar irradiation on exophthalmos, ductions and soft tissue signs in Graves ophthalmopathy: A retrospective analysis of 90 cases. Eye 2000, 5: 761-764.
34. Margo C.E. The placebo effect. Surv. Ophthalmol. 1999, 44: 31-44.
35. Kahaly G.J., Gorman C.A., Kal H.B. et al. Radiotherapy for Graves' ophthalmopathy. In: Prummel M.F., Wiersinga W.M., Mourits M.Ph., Heufelder A.E. (Eds.), Recent Developments in Graves' Ophthalmopathy, Kluwer Academic Publishers, Boston/Dordrecht/London 2000, p. 115.
36. Petersen I.A., Kriss J.P., McDougall J.R. et al. Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int. J. Radiat. Oncol. Biol. Phys. 1990; 19: 259-264.
37. Kahaly G.J., Rösler H.-P., Pitz S. et al. Low-versus high-dose radiotherapy for Graves' ophthalmopathy: A randomized, single blind trial. J. Clin. Endocrinol. Metab. 2000, 85: 102-108.
38. Beckendorf V., Manlouf T., George J.-L. et al. Place of radiotherapy in the treatment of Graves' ophthalmopathy. Int. J. Radiat. Oncol. Biol. Phys. 1999, 43: 805-815.
39. Kinyoun J.L., Kalina R.E., Brower S.A. et al. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy. Arch. Ophthalmol. 1984, 102: 1473-1476.
40. Polak B.C.P., Wijngaarde R. Radiation retinopathy in patients with both diabetes mellitus and ophthalmic Graves' disease. Orbit 1995, 14: 71-74.
41. Viebahn M., Barricks M.E., Osterloh M.D. Synergism between diabetic and radiation retinopathy; Case report and review. Brit. J. Ophthalmol. 1991, 75: 629-632.
42. Miller M.L., Goldberg S.H., Bullock J.D. Radiation retinopathy after standard radiotherapy for thyroid related ophthalmopathy. Am. J. Ophthalmol. 1991, 112: 600-601.
43. Nygaard B., Specht L. Transitory blindness after retrobulbar irradiation of Graves' ophthalmopathy. Lancet 1998, 351: 725-726.
44. Snijders-Keiholz A., De Keizer R.J.W., Goslings B.M. et al. Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy. Radiother. Oncol. 1996, 38: 69-71.
45. Blank L.E.C.M., Barendsen G.W., Prummel M.F. et al. Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy. Radiother. Oncol. 1996, 40: 187-188.
46. Broerse J.J., Snijders-Kielholz A., Jansen J.T.M. et al. Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry. Radiother. Oncol. 1999, 53: 205-208.
47. Schaefer U., Hesselmann S., Micke O. et al. A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy. Int. J. Radiat. Oncol. Biol. Phys. 2002, 52: 192-197.
48. Bartley G.B., Fatourechi V., Kadrmas E.F. et al. Long-term follow-up of Graves' ophthalmopathy in an incidence cohort. Ophthalmology 1996, 103: 958-962.
49. Gerding M.N., Terwee C.B., Dekker F.W., Koornneef L., Prummel M.F., Wiersinga W.M. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: Measurement by the Medical Outcomes Study Instrument. Thyroid 1997, 7: 885-889.
50. Cockerham K.P., Kennerdell J.S. Does radiotherapy have a role in the management of thyroid orbitopathy? View 1. Br. J. Ophthalmol. 2002, 86: 102-104.
51. Mourits M.P. Does radiotherapy have a role in the management of thyroid orbitopathy? View 2. Br. J. Ophthalmol. 2002, 86: 104-106.
52. Feldon S.E. Radiation therapy for Graves' ophthalmopathy: Trick or treat? Ophthalmology 2001, 108: 1521-1522.
53. Prummel M.F., Mourits M.P., Blank L., Berghout A., Koornneef L., Wiersinga W.M. Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 1993, 342: 949-954.
54. Marcocci C., Bartalena L., Bogazzi F., Bruno-Bossio G., Lepri A., Pinchera A. Orbital radiotherapy combined with high-dose systemic glucocorticoids is more effective than orbital radiotherapy alone: Results of a prospective study. J. Endocrinol. Invest. 1991, 14: 853-860.